The advertisement promotes Entyvio (adalimumab) as a superior treatment option to Humira for patients with moderately to severely active ulcerative colitis, highlighting its efficacy in clinical remission and providing important safety information.
Creative Information
| CID: | 97ce10d3-fca1-4914-b4e9-c4bab3168acb |
| CRID: | 82_6854-857429 |
| Domain: | entyviohcp.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $0.13 |
| Timestamp: | 11/4/2025, 4:18:08 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 5:32:11 PM | 7.63s | |
| adomain_analysis | success | 11/4/2025, 7:39:59 PM | 4.29s | |
| adomain_capture | success | 11/4/2025, 7:39:46 PM | 0.13s | |
| ad_render | success | 11/4/2025, 5:32:03 PM | 25.71s | |
| brand_mapping | success | 11/4/2025, 4:18:08 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: Entyvio
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1762.68 KB | ||||||||||||||||||||||
| Render Time: | 10.10 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1762.76 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

